Linda Katz, director of the US Food and Drug Administration’s Office of Cosmetics and Colors, will retire 11 January, following 22 years leading the agency’s cosmetics regulatory efforts.
FDA Cosmetics Director Katz Retires After 22 Years; Manga To Lead OCAC On Acting Basis
Linda Katz presided over a two-decade-long effort to boost FDA’s authority over cosmetic product safety during her time as director of the Office of Cosmetics and Colors. She will retire in January.
More from Regulation
• By
Counterfeit beauty products cost the US industry an estimated $3bn in 2023, says a trade expert during the Personal Care Products Council’s Beauty Collective Summit.
• By
Cosmetics companies brace for the impact of Trump administration tariffs as industry experts seeing an opportunity for an exemption urge stakeholders to reach out to lawmakers. The issue was discussed during PCPC’s recent Beauty Collective Summit.
• By
The Washington Department of Ecology releases its formal draft rule under the Toxic Free Cosmetics Act listing 28 intentionally added formaldehyde releasers, with plans to adopt the rule this summer.
• By
Beauty industry insiders from trade associations and attorneys specializing in marketing law and/or cosmetics manufacturing look forward to a more business-friendly FTC in the US in 2025, while they expect industry to face an increasing number of challenges at the state level. Meanwhile, the EU beauty market is hopeful it will see reduced regulations this year.
More from HBW Insight
• By
Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.